Track topics on Twitter Track topics that are important to you
Seattle Genetics has agreed to acquire Bristol-Myers Squibb (BMS)’s Monte Villa Parkway Research Center, a Bothell, WA, pharmaceutical manufacturing facility, for a combined $43.3 million. Seattle Genetics said it plans to use the facility primarily for antibody production for current and future pipeline programs. The facility would be the company’s first manufacturing site, having relied until now on contract manufacturers. “This turnkey manufacturing facility provides the capability, capacity, and skilled workforce needed to support our expanding antibody–drug conjugate and immuno-oncology pipeline, and complements our existing outsourced manufacturing model,” Vaughn Himes, Ph.D., Seattle Genetics CTO, said in a statement. “Its location near our corporate headquarters will provide operational synergies with our current technical operations team and underscores our strategy for continued growth in Washington state.” Monte Villa Parkway Research Center is some 20 blocks south of Seattle Genetics’ headquarters campus, where the company now leases seven buildings. ...
Original Article: Seattle Genetics Acquires BMS Manufacturing Site in Bothell, WANEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...